ALFA Filings
Every announcement, straight from the exchange
Every Lupin product launch announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements with these filters
Lupin Limited launched Formoflo-G® MDI, the world's first fixed-dose triple combination inhaler for COPD management in India. This follows approval from the Drug Controller General of India.
Lupin received US FDA approval for Modafinil Tablets, USP, a generic version of Provigil. This regulatory approval enables the company to market the drug in the U.S.